Science
Muhammad Umair Mushtaq: Outcomes after Matched Sibling Donor Versus Haploidentical HSCT
Muhammad Umair Mushtaq/LinkedIn

Muhammad Umair Mushtaq: Outcomes after Matched Sibling Donor Versus Haploidentical HSCT

Muhammad Umair Mushtaq, Associate Professor of Medicine at University of Kansas Medical Center, shared on X:

“Publication 101 indexed in PubMed/NLM.

Grateful to our mentors, collaborators, trainees, and patients who make this work possible.

Mushtaq MU, et al. Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis. Transplantation and Cellular Therapy 2026.”

Title: Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis

Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Tahereh Rostami, Muhammad Kashif Amin, Shayan Forghani, Hediyeh Alemi, Naghmeh Khavandgar, Shah Rukh, Khalid Halahleh, Anurag K. Singh, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad․

Read the full article

Muhammad Umair Mushtaq

You can also read other articles featuring Muhammad Umair Mushtaq on OncoDaily.

 

Al-Ola Abdallah Amir Kasaeian Anurag K. Singh cancer Cellular Therapy Hediyeh Alemi Joseph P. McGuirk Khalid Halahleh Mehdi Hamadani Moazzam Shahzad Muhammad Kashif Amin Muhammad Umair Mushtaq Naghmeh Khavandgar NLM OncoDaily Oncology Pubmed Shah Rukh Shayan Forghani Tahereh Rostami Transplantation University of Kansas Medical Center